Investing.com-- Most Asian stock markets fell on Tuesday, led by declines in Japan and Hong Kong, as investors turned ...

Brent Oil Futures expiring in September inched up 0.1% to $70.09 a barrel by 21:53 ET (01:53 GMT), while U.S. West Texas Intermediate (WTI) crude futures were muted at $66.74 per barrel. Both ...

Investing.com-- The U.S. and China are expected to extend their tariff truce by an additional 90 days during trade talks starting Monday in Stockholm, the South China Morning Post ...

Investing.com -- GBank Financial Holdings Inc. (NASDAQ: GBFH) shares tumbled 5.4% after the company reported second quarter earnings that fell short of analyst expectations, despite posting record ...

Brown & Brown’s results come as the company prepares for its pending acquisition of RSC Topco, Inc., with approximately $13 million of interest income earned from proceeds of the company’s follow-on ...

Investing.com -- Loandepot Inc (NYSE: LDI) stock rose 3.6% after the company announced that founder Anthony Hsieh has been appointed permanent Chief Executive Officer, effective immediately. Hsieh had ...

Investing.com -- Ranger Energy Services Inc (NYSE: RNGR) stock surged 5.9% in afterhours trading following the company’s announcement of its first Hybrid Double Electric Workover Rig development, ...

Investing.com -- Verizon Communications (NYSE: VZ) is expanding its Manhattan footprint by leasing 200,000 square feet in a ...

NEW YORK - CNO Financial Group (NYSE: CNO) reported second-quarter adjusted earnings that slightly exceeded analyst expectations, as the company continues to make progress toward its 2025-2027 return ...

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...

Investing.com -- PTC (NASDAQ: PTC) Therapeutics (NASDAQ: PTCT) stock rose 9% after the company announced that the U.S. Food and Drug Administration (FDA) has approved its drug SEPHIENCE (sepiapterin) ...

Investing.com -- Metsera , Inc. (NASDAQ: MTSR ), a clinical-stage biopharmaceutical company focused on obesity and metabolic diseases, reported a wider-than-expected second quarter loss on Monday, ...